| __timestamp | BioCryst Pharmaceuticals, Inc. | Corcept Therapeutics Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 13608000 | 26551000 |
| Thursday, January 1, 2015 | 48257000 | 50286000 |
| Friday, January 1, 2016 | 26353000 | 81321000 |
| Sunday, January 1, 2017 | 25186000 | 159201000 |
| Monday, January 1, 2018 | 20653000 | 251247000 |
| Tuesday, January 1, 2019 | 48835000 | 306486000 |
| Wednesday, January 1, 2020 | 17812000 | 353874000 |
| Friday, January 1, 2021 | 157170000 | 365978000 |
| Saturday, January 1, 2022 | 270827000 | 401858000 |
| Sunday, January 1, 2023 | 331412000 | 482375000 |
In pursuit of knowledge
In the competitive landscape of biotechnology, revenue growth is a key indicator of success. Over the past decade, Corcept Therapeutics Incorporated and BioCryst Pharmaceuticals, Inc. have shown remarkable trajectories. Corcept Therapeutics has consistently outpaced BioCryst, with its revenue growing nearly 18 times from 2014 to 2023. In 2014, Corcept's revenue was approximately double that of BioCryst, and by 2023, it had grown to nearly 50% more than BioCryst's revenue. This growth highlights Corcept's strategic advancements in the pharmaceutical sector.
BioCryst, while trailing, has also demonstrated significant growth, particularly from 2020 onwards, with a revenue increase of over 18 times from 2014 to 2023. This surge reflects BioCryst's successful product launches and market expansions. As both companies continue to innovate, their revenue trends offer valuable insights into the evolving dynamics of the biotech industry.
Novo Nordisk A/S vs BioCryst Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Comparing Revenue Performance: Sanofi or BioCryst Pharmaceuticals, Inc.?
Annual Revenue Comparison: Biogen Inc. vs BioCryst Pharmaceuticals, Inc.
Breaking Down Revenue Trends: Dr. Reddy's Laboratories Limited vs Corcept Therapeutics Incorporated
Jazz Pharmaceuticals plc and Corcept Therapeutics Incorporated: A Comprehensive Revenue Analysis
Jazz Pharmaceuticals plc vs BioCryst Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Revenue Insights: Grifols, S.A. and Corcept Therapeutics Incorporated Performance Compared
Revenue Insights: Corcept Therapeutics Incorporated and Veracyte, Inc. Performance Compared
Corcept Therapeutics Incorporated vs Merus N.V.: Examining Key Revenue Metrics
Research and Development Investment: Corcept Therapeutics Incorporated vs BioCryst Pharmaceuticals, Inc.
Annual Revenue Comparison: Ionis Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis